Clinical Trials

56 enrolled

Esophageal Neoplasms

NCT01249352 2025-03-31

NICE

Phase 2/3 Completed

104 enrolled

Adenocarcinoma, Esophageal Neoplasms

NCT05278728 2025-02-07

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Phase 1/2 Completed

31 enrolled

Colorectal Neoplasms

NCT04207918 2024-05-16

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

55 enrolled

Esophageal Neoplasms

NCT06363084 2024-04-12

A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Completed

64 enrolled

Resectable Pancreatic Cancer

NCT02395016 2024-04-04

A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Phase 3 Completed

90 enrolled 18 charts

Pancreatic Neoplasms

NCT02947386 2023-10-05

Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer

Phase 1 Completed

7 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00702481 2023-02-28

Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

32 enrolled

Head and Neck Neoplasms

NCT04475016 2022-06-09

TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer

29 enrolled

Genitourinary

Penile Neoplasms

NCT04508816 2022-04-04

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

45 enrolled

Nasopharyngeal Carcinoma

NCT02591784 2022-03-17

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

42 enrolled

Esophageal

NCT03413579 2021-08-25

CIMAHOPE

Phase 3 Completed

37 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT02577341 2021-02-11

Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer

122 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01463605 2021-02-04

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

46 enrolled

Esophageal Neoplasms

NCT03388372 2018-01-03

Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma

39 enrolled

CNS

Glioblastoma, Glioma

NCT00561990 2015-10-15

Nimotuzumab in Adults With Pancreatic Cancer

Phase 2/3 Completed

188 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01616849 2015-09-22

Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma

39 enrolled

Nasopharyngeal Carcinoma

NCT00950417 2015-08-19

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Phase 1 Completed

11 enrolled

Advanced Esophageal

NCT02095119 2015-04-14

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Phase 1/2 Completed

15 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02370849 2015-02-25

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

2 enrolled

Stomach Neoplasms

NCT01498562 2014-12-02

DATE

160 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01425736 2014-06-03

Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma

91 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00910117 2012-02-20

Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

40 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00600054 2011-07-06

Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma